Triphenylphosphine → (1S,4R)-4-[2-Chloro-6-(2,2-diphenyl-ethylamino)-purin-9-yl]-cyclopent-2-enol

HRID 1641881ノート

反応式

HRID 1641881 の反応式
[Cl:1][C:2]1[N:10]=[C:9]2[C:5]([N:6]=[CH:7][NH:8]2)=[C:4]([NH:11][CH2:12][CH:13]([C:20]2[CH:25]=[CH:24][CH:23]=[CH:22][CH:21]=2)[C:14]2[CH:19]=[CH:18][CH:17]=[CH:16][CH:15]=2)[N:3]=1.[H-].[Na+].CC([O:31][C@H:32]1[CH:36]=[CH:35][C@@H:34](O)[CH2:33]1)=O.C1(P(C2C=CC=CC=2)C2C=CC=CC=2)C=CC=CC=1>C1C=CC([P]([Pd]([P](C2C=CC=CC=2)(C2C=CC=CC=2)C2C=CC=CC=2)([P](C2C=CC=CC=2)(C2C=CC=CC=2)C2C=CC=CC=2)[P](C2C=CC=CC=2)(C2C=CC=CC=2)C2C=CC=CC=2)(C2C=CC=CC=2)C2C=CC=CC=2)=CC=1>[Cl:1][C:2]1[N:10]=[C:9]2[C:5]([N:6]=[CH:7][N:8]2[C@@H:35]2[CH2:36][C@H:32]([OH:31])[CH:33]=[CH:34]2)=[C:4]([NH:11][CH2:12][CH:13]([C:14]2[CH:19]=[CH:18][CH:17]=[CH:16][CH:15]=2)[C:20]2[CH:25]=[CH:24][CH:23]=[CH:22][CH:21]=2)[N:3]=1

参加物

6

実験手順

(2-Chloro-9H-purin-6-yl)-(2,2-diphenyl-ethyl)-amine (12.92 g, 36.97 mmol) is placed in an oven-dried flask under an atmosphere of argon. Dry deoxygenated THF (100 mL) and dry DMSO (2 mL) are added and the suspension is cooled on an ice-bath. Sodium hydride 95% (0.89 g, 36.97 mmol) is then slowly added and the solution is stirred at room temperature for 30 minutes. (1S,4R)-cis 4-Acetoxy-2-cyclopenten-1-ol (5.00 g. 35.20 mmol) and triphenyl-phosphine (1.38 g, 5.28 mmol) are placed in an oven-dried flask under an atmosphere of argon. Dry deoxygenated THF (50 mL) is added. This solution is added to the anion solution via syringe. Tetrakis(triphenylphosphine)palladium(0) (2.03 g, 1.76 mmol) is then added and the reaction mixture is stirred at 50° C. for 3 hours. The reaction mixture is allowed to cool and the solvent is removed in vacuo. The residue is taken up in dichloromethane (50 ml) and poured into vigorously stirring diethyl ether (300 mL). The precipitate is filtered off, the filtrate is taken and the solvent is removed in vacuo to give the title compound. 1H nmr (CDCl3, 400 MHz); 7.65 (m, 1H), 7.35-7.15 (m, 10H), 6.35 (m, 1H), 5.90 (m, 1H), 5.80 (m, 1H), 5.50 (m, 1H), 5.25 (d, 1H), 4.85 (t, 1H), 4.35 (t, 1H), 4.25 (m, 2H), 2.95 (m, 1H), 2.15 (d, 1H), MS (ES+) m/e 432 (MH+).

後処理

  1. customDry
  2. customdeoxygenated THF (100 mL) and dry DMSO (2 mL)
  3. additionare added
  4. temperaturethe suspension is cooled on an ice-bath
  5. customDry
  6. customdeoxygenated THF (50 mL)
  7. additionis added
  8. additionThis solution is added to the anion solution via syringe
  9. stirringthe reaction mixture is stirred at 50° C. for 3 hours
  10. temperatureto cool
  11. customthe solvent is removed in vacuo
  12. additionpoured into vigorously stirring diethyl ether (300 mL)
  13. filtrationThe precipitate is filtered off
  14. customthe solvent is removed in vacuo

出典と根拠

ORDレコード
ord-b1685ecfb0894a60bd5385ca2e312516
出典データセット
uspto-grants-2012_02
特許番号
US08114877B2

反応ノート

読み込み中…